Search results
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
Barrons.com· 1 day agoThe American Society of Clinical Oncology is set to gather on May 31 in Chicago for its annual...
Here's Why Merck (MRK) Stock Has Outperformed Industry YTD
Zacks via Yahoo Finance· 5 days agoMerck MRK boasts more than six blockbuster drugs in its portfolio, with PD-L1 inhibitor Keytruda...
Is Merck & Co., Inc. (NYSE:MRK) the Best Dow Stock To Buy According to Hedge Funds?
Insider Monkey via Yahoo Finance· 3 hours agoWe recently identified the best dow stocks according to hedge funds. Even though Merck & Co., Inc....
Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting
Digital Journal· 3 days agoIndividualized neoantigen therapies are designed to train and activate an antitumor immune response by generating specific T-cell responses based on the unique mutational signature of a patient's ...
Why Is Cancer-Focused Merus Stock Trading Over 30% On Friday?
Benzinga via Yahoo Finance· 1 day agoKeytruda (pembrolizumab) is Merck & Co Inc’s (NYSE:MRK) top selling cancer drug. The abstract...
ASCO 2024: Merus touts positive Phase II data for head and neck cancer antibody
Pharmaceutical Technology via Yahoo Finance· 1 day agoThe Phase II study is evaluating petosemtamab in combination with Merck & Co’s PD-1 inhibitor ...
Iovance (IOVA) Up 5% on Updated Data From Melanoma Study
Zacks via Yahoo Finance· 1 day agoIovance (IOVA) shares updated data from a mid-stage study, which showed that treatment with its...
Why Top 4% Biotech Stock, Merus, Just Catapulted To A Record High
Investor's Business Daily· 1 day agoThe Netherlands-based biotech paired its drug, petosemtamab, with Merck's cancer blockbuster, ...
ASCO24: An early look at cancer drug study results
BioPharma Dive via Yahoo Finance· 2 days agoClinical trial abstracts posted Thursday ahead of this year’s ASCO meeting give a peek at anticipated datasets from Immunocore, Merus, J&J and Merck &...
Billionaire Ken Griffin Is Buying These Dividend Stocks Hand Over Fist. Should You?
Motley Fool via Yahoo Finance· 1 day agoThe big drugmaker's forward dividend yield stands at nearly 2.4%. The stock is on a roll so far in...